← FDA Drug Approvals (Drugs@FDA)
HERNEXEOS
NDA · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2025-08-08
Drug application
- FDA Application #
NDA219042- Application type
- New Drug Application
- Brand name
- HERNEXEOS
- Generic name
- ZONGERTINIB
- Active ingredients
- ZONGERTINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- BOEHRINGER INGELHEIM
- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- First approval
- 2025-08-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown